[Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy]

Hinyokika Kiyo. 1986 Nov;32(11):1584-9.
[Article in Japanese]

Abstract

The plasma luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin, testosterone and human growth hormone (HGH) response to insulin-induced hypoglycemia in patients with benign prostatic hypertrophy and age-matched control patients were not different. Although all 6 drugs used were effective for treating these benign prostatic hypertrophy patients the 3 drugs, chlormadinone acetate, oxendrone and allylestrenol, were especially recommended.

Publication types

  • English Abstract

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Follicle Stimulating Hormone / blood
  • Growth Hormone / blood
  • Hormones / blood*
  • Humans
  • Luteinizing Hormone / blood
  • Male
  • Prolactin / blood
  • Prostatic Hyperplasia / blood
  • Prostatic Hyperplasia / drug therapy*
  • Testosterone / blood

Substances

  • Androgen Antagonists
  • Hormones
  • Testosterone
  • Prolactin
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Growth Hormone